In Chile, where abortion remains illegal and punishable by imprisonment, we follow a group of young activists who run an underground abortion hotline. Our protagonist Mafe is backed by a group of trusted volunteers who dedicate their evenings to answering calls and advising pregnant women in distress. Their goal: to inform callers about Misoprostol, a pill used to treat ulcers that can also induce abortion.
But change is in the air. After a heated election campaign, new President Michelle Bachelet has promised to loosen certain laws related to abortion. As the debate intensifies we witness first hand the trials and tribulations of the hotline as they find themselves taking centre stage. Election promises become diluted, allegiances are formed and broken with opportunists profiting from illegal abortions and the countries deep divisions are laid bare.
Can the hotline survive personal differences, will they remain safe from the authorities or will progressive reforms render the abortion hotline obsolete?
The Abortion Hotline from Sideways Film on Vimeo.
Stem Cell research and therapy have been growing at a rapid rate over the past fifteen years. Scientific advances coupled with consumer demand have proven that stem cell therapy is the wave of the future, and is poised to change the face of medicine.
The only hurdles have been religious and regulatory roadblocks slowing down the approval process for fetal stem cell therapy, arguably the most contested and controversial form of stem cell therapy to date, due to them being harvested from abortions.
The God Cells takes the audience on a journey with those who seek the life changing fetal stem cell therapy abroad, while avoiding the seemingly insurmountable roadblocks at home.
“The demand is real, patients with current unmet medical needs are desperate and require this therapy, but the current regulatory and industry hurdles are making it near impossible for us to do our job and get these important stem cell therapies to those people in need. Because of this, many scientific organizations are taking their technology abroad to appease patient demand, because they feel the current regulatory hurdles are insurmountable.”
Randal Mills, PhD, President and CEO for California Institute For Regenerative Medicine